Acute Pancreatitis: An Unusual Side Effect of Adalimumab in Crohn’s Disease Patient
Background: Drug-induced acute pancreatitis is a rare condition occurs at an incidence rate of 0.1–1.4% and represents a diagnostic challenge. TNFα inhibitors specially adalimumab is very rarely reported in the literature, primarily through case reports, as a potential cause of acute pancreatitis. C...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2025-01-01
|
Series: | Clinical Medicine Insights: Case Reports |
Online Access: | https://doi.org/10.1177/11795476251315000 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|